2021-2022 Pediatric Flu Vaccine
Awarded Award Notice Posted
- Solicitation number
- 68173
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D3012110216
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Wilmington DE 19803 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services announces the award of a $377,600,000 contract to AstraZeneca Pharmaceuticals LP for the 2021-2022 pediatric flu vaccine. The contract was awarded on December 28, 2020 to provide 377,600,000 doses of the pediatric flu vaccine to support public health efforts over the next two years.
Notice text
This is a notice of award.
Awarded contract 75D3012110216 to ASTRAZENECA PHARMACEUTICALS LP for 377600000.00 on 2020-12-28.
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2021-2022 Pediatric Flu Vaccine | Award Notice | |
| 2021-2022 Pediatric Flu Vaccine | Award Notice | |
| 202-2022 Pediatric Flu Vaccine | Award Notice | |
| 2021-2022 Pediatric Flu Vaccine | Award Notice | |
| 2021 Pediatric Flu Vaccine | Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity